Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
LIVE CHICKEN ANAEMIA VIRUS (CAV), STRAIN CUX-1 PH. EUR.
Lohmann Animal Health GmbH
QI01AD04
LIVE CHICKEN ANAEMIA VIRUS (CAV), STRAIN CUX-1 PH. EUR.
Unknown
Oral Lyophilisate
POM
Fowl - Chicken
Chicken anaemia vaccine
Immunological - Live Vaccine
Authorised
2008-12-12
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT AviPro Thymovac Lyophilisate for use in drinking water. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 dose contains: ACTIVE SUBSTANCE: live Chicken Anaemia Virus (CAV), strain Cux-1 : 10 4.5 - 10 5.5 TCID 50 * * TCID 50 = tissue culture-infectious dose 50%: the virus titre required to cause infection in 50% of the inoculated cell cultures EXCIPIENTS: For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Lyophilisate for use in drinking water. Appearance: red to brown lyophilized cake 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (breeders from 8 weeks of age) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For protection of the vaccinated breeder against excretion of the chicken anaemia virus and transmission of the virus to eggs. For this active immunisation, onset of immunity: 4 weeks duration of immunity: 43 weeks demonstrated by challenge. For passive protection conferred to the progeny against clinical signs and lesions of chicken anaemia. The protection of the progeny is guaranteed for up to 51 weeks after vaccination of the breeder, and chicks are protected at one day old (as demonstrated by challenge). 4.3 CONTRAINDICATIONS Do not use in unhealthy birds. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 30/08/2013_ _CRN 7014067_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Vaccination should be performed from 8 weeks of age onwards, but no later than 6 weeks before the onset of lay in order to ensure that protective immunity has developed prior to the onset of lay. The vaccine virus may s Pročitajte cijeli dokument